Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients
Feb 18, 2025
―
Suvn-I6107
Healthy
Phase I
Recruiting
Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SUVN-I6107 In Healthy Participants
Nov 14, 2024
―
Ropanicant
Major Depressive Disorder
Phase II
Completed
Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients
Nov 06, 2023
―
Masupirdine 50 Mg, Masupirdine 100 Mg
Agitation, Alzheimer's Type Dementia
Phase III
Recruiting
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
May 25, 2022
―
Suvn-G3031
Narcolepsy
Phase II
Completed
A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy
Aug 26, 2019
―
Suvn-911
Major Depressive Disorder
Phase I
Completed
Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-911 in Healthy Subjects
May 28, 2018
―
Suvn-911
Depressive Disorder, Major
Phase I
Completed
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects
May 11, 2017
―
Suvn-D4010
Cognitive Disorder
Phase I
Completed
A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-D4010 in Healthy Subjects
Jan 23, 2017
―
Suvn-G3031
Cognitive Disorders
Phase I
Completed
A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-G3031 in Healthy Subjects
Aug 18, 2016
―
Donepezil, Suvn-502, Memantine
Alzheimer's Disease
Phase II
Completed
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
Oct 17, 2015
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Suven Life Sciences Limited (SUVEN) have in its pipeline
SUVEN is currently developing the following drugs: Ropanicant, Suvn-I6107, Ropanicant. These drug candidates are in various stages of clinical development as the company works toward FDA approval.